SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (10039)5/17/1999 11:04:00 AM
From: Gary105  Respond to of 17367
 
looking for summary of meningitis test status as i am doing dd. as i understand situation from posts, they will release results of study during summer. i am a little confused about the issue of ending tests early (which they didnt). another poster claimed that mortality rates are unchanged or at least not good enough to end tests early. how does he know? any insight would be appreciated. thanks



To: aknahow who wrote (10039)5/17/1999 11:04:00 AM
From: Arthur Radley  Read Replies (1) | Respond to of 17367
 
I might have to pinch myself this morning to make sure I'm awake. First XOMA is showing a little spark and then another of my holdings just announced a tax free spin off......Harcourt is spinning off to shareholders their stake in Neiman Marcus. With my new 300 shares of Neiman stock and XOMA flying high, I might now be able to shop at Neiman.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News